Perioperative Pain Management for Complex Pancreatic Resections for Patients with Chronic Pancreatitis.
Supradeep S Madduri, Kristen R Szempruch, Dhruv J Patel, Melissa E Chen, Chirag S Desai
Pancreas May 12, 2025 DOI: 10.1097/MPA.0000000000002513 (opens in new tab) via PubMed
Summary
AI-generated from the abstractAfter pancreatic surgery for chronic pancreatitis, ketamine infusions provide pain relief comparable to epidural analgesia without increasing opioid use. In a cohort of 65 patients, those receiving ketamine (26 patients, mostly after total pancreatectomy with islet cell auto-transplantation) and those receiving epidural analgesia (39 patients, mostly after parenchyma-preserving pancreatic surgery) showed no significant difference in opioid consumption at discharge (median 75 vs 60 morphine milligram equivalents) or in pain scores. Adverse effects from ketamine were minimal, with hallucinations being the most common reaction (4 patients). Ketamine appears to be a safe and effective alternative for pain management when epidurals are not suitable.
Study at a glance
| Characteristics | Cohort study Peer reviewed |
|---|---|
| Sample size | 65 |
| Population | Patients 16 years or older with chronic pancreatitis undergoing pancreatectomy |
| Interventions | Ketamine infusion Epidural analgesia |
| Topics | Ketamine |
| Keywords | Whipple Chronic pancreatitis Islet cell autotransplantation Pain management Pancreatectomy |
| Citations | 1 |
| Key finding | Ketamine provided similar opioid-sparing analgesia compared to epidural analgesia in patients undergoing pancreatic surgery for chronic pancreatitis. |
Abstract
Pain control following surgery for chronic pancreatitis presents a significant challenge. Options like epidurals used in parenchymal preserving pancreatic surgery (PPS) are contraindicated in certain settings such as total pancreatectomy (TP) with islet cell auto-transplantation (IAT). Our aim is to assess the efficacy and safety of ketamine in these patients and compare it to that of epidural analgesia. A single-center, cohort study was conducted in patients 16 years or older with chronic pancreatitis from August 2017 to May 2023 who underwent pancreatectomy. Patients were stratified based on ketamine infusion group vs epidural group. Primary outcome was change in morphine milligram equivalent (MME) from preoperative to discharge. Secondary outcomes were pain scores at postoperative day one to five and associated complications. Sixty-five patients were included (ketamine group 26 (40%) and epidural 39 (60%)). Ninety six percent (25/26) of patients in the ketamine group underwent TPIAT and 87% of patients in the epidural group (34/39) underwent PPS. There was no difference in opioid consumption preoperatively, or at time of discharge [ketamine, median MME 75 (IQR 47-90) vs epidural, median MME 60 (IQR 45-90), P=0.279] and in pain scores. Adverse events were minimal, with hallucinations (n=4) as the most common ketamine related reaction. Ketamine provided similar opioid sparing analgesia compared to opioid epidurals. Ketamine is a promising adjunctive analgesic in patients with chronic pancreatitis.